Anti-hepatitis C: Began Phase II trial

Cangene Corp. (TSE:CNJ), Toronto, Ontario Product: Anti-hepatitis C Business: Infectious diseases Therapeutic category: Immune stimulation Target: Hepatitis C antigens Description: Anti-hepatitis C hy...